Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial

被引：42

作者：

Schneider, LS ^{[1
]}

Ismail, MS ^{[1
]}

Dagerman, K ^{[1
]}

Davis, S ^{[1
]}

Olin, J ^{[1
]}

McManus, D ^{[1
]}

Pfeiffer, E ^{[1
]}

Ryan, JM ^{[1
]}

Sultzer, DL ^{[1
]}

Tariot, PN ^{[1
]}

机构：

[1] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA

来源：

SCHIZOPHRENIA BULLETIN | 2003年 / 29卷 / 01期

关键词：

Alzheimer's disease; atypical antipsychotic; psychosis; dementia; effectiveness;

D O I：

10.1093/oxfordjournals.schbul.a006991

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

This article describes the development of the protocol for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Alzheimer's disease trial, which was developed in collaboration with the National Institute of Mental Health to assess the effectiveness of atypical antipsychotics for psychosis and/or agitation occurring in outpatients with Alzheimer's disease. The article provides a detailed description of the methodology used in the trial as well as the clinical outcomes and effectiveness measures incorporated into it, discussing the most salient issues encountered in developing the design of the trial, as well as the unique features of the trial.

引用

页码：57 / 72

页数：16

共 50 条

[41] Role of meta-analysis of clinical trials for Alzheimer's disease
Arrieta, JML
DRUG DEVELOPMENT RESEARCH, 2002, 56 (03) : 401 - 411
[42] Drug candidates in clinical trials for Alzheimer’s disease
Shih-Ya Hung
Wen-Mei Fu
Journal of Biomedical Science, 24
[43] Alzheimer’s Disease Clinical Trials: Changing the Paradigm
Jeffrey L. Cummings
Current Psychiatry Reports, 2011, 13 : 437 - 442
[44] BACE Inhibitor Clinical Trials for Alzheimer's Disease
Watkins, Elyse A.
Vassar, Robert
JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 : S41 - S52
[45] Applications of Alzheimer's disease staging to clinical trials
Therriault, Joseph
Gauthier, Serge
Rosa-Neto, Pedro
AGING-US, 2023, 15 (01): : 1 - 2
[46] Clinical Trials of Intravenous Immunoglobulin for Alzheimer’s Disease
Norman Relkin
Journal of Clinical Immunology, 2014, 34 : 74 - 79
[47] Therapeutic strategies for Alzheimer’s disease in clinical trials
Justyna Godyń
Jakub Jończyk
Dawid Panek
Barbara Malawska
Pharmacological Reports, 2016, 68 : 127 - 138
[48] Biochemical markers in Alzheimer's disease clinical trials
Zetterberg, Henrik
Mattsson, Niklas
Shaw, Les M.
Blennow, Kaj
BIOMARKERS IN MEDICINE, 2010, 4 (01) : 91 - 98
[49] Therapeutic strategies for Alzheimer's disease in clinical trials
Godyn, Justyna
Jonczyk, Jakub
Panek, Dawid
Malawska, Barbara
PHARMACOLOGICAL REPORTS, 2016, 68 (01) : 127 - 138
[50] Iron Chelators and Alzheimer's Disease Clinical Trials
Mandal, Pravat K.
Maroon, Joseph C.
Samkaria, Avantika
Arora, Yashika
Sharma, Shallu
Pandey, Ashutosh
JOURNAL OF ALZHEIMERS DISEASE, 2024, 100 : S243 - S249

← 1 2 3 4 5 →